Trial Details

COMPLETED
Basic Information
Clinical ID c4015
Identifier NCT01177410
Trial Title Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Irritable Bowel Syndrome With Diarrhea
Interventions DRUG: Placebo|DRUG: Mesalamine Granules 750 mg|DRUG: Mesalamine Granules 1500 mg
Participant Information
Sponsor Bausch Health Americas, Inc.
City Sherwood
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2010-07
Primary Completion Date 2011-08
Completion Date 2011-08